Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | CASP6 | P55212 | 1/20 | 0.54 |
| ▸ | NQO2 | P16083 | 1/20 | 0.46 |
| ▸ | CCR1 | P32246 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CCR5 | P51681 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31186677 | 1.00 | CYP1A2 (0.60) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL10259445 | 0.87 | CYP1A2 (0.68) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL9217980 | 0.84 | CYP1A2 (0.65) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL25105737 | 0.82 | CYP1A2 (0.52) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL9186322 | 0.82 | CYP1A2 (0.52) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL244724 | 0.82 | CYP1A2 (0.52) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL13737917 | 0.79 | CYP1A2 (0.48) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL29324287 | 0.79 | CYP1A2 (0.48) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL23872164 | 0.79 | CYP1A2 (0.48) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL28909998 | 0.78 | ALDH1A1 (0.51) | CYP1A2KDM4ELMNAPOLBCASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3981433-A1 | COVALENT LINKERS IN ANTIBODY-DRUG CONJUGATES AND METHODS OF MAKING AND USING THE SAME | RemeGen Biosciences, Inc. (US) | 2022-04-13 | — | — | EP | disclosed |
| CN-106543078-B | A kind of preparation method of quinoline | 中国科学院兰州化学物理研究所苏州研究院 | 2019-01-11 | — | — | CN | disclosed |
| EP-2880080-B1 | POLYMERS, POLYMER MEMBRANES AND METHODS OF PRODUCING THE SAME | AIR PROD & CHEM (US) | 2018-07-04 | — | — | EP | disclosed |
| US-20180053868-A1 | PHOTOELECTRIC CONVERSION DEVICE HAVING REFLECTION PLATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-22 | — | — | US | disclosed |
| US-20180053868-A1 | PHOTOELECTRIC CONVERSION DEVICE HAVING REFLECTION PLATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-22 | — | — | US | disclosed |
| US-20170162808-A1 | PHOTOELECTRIC CONVERSION DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20170162808-A1 | PHOTOELECTRIC CONVERSION DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-06-08 | — | — | US | disclosed |
| CN-106543078-A | A kind of preparation method of quinoline | 中国科学院兰州化学物理研究所苏州研究院 | 2017-03-29 | — | — | CN | disclosed |
| US-20160372675-A1 | MACROMOLECULAR COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-12-22 | — | — | US | disclosed |
| US-9512149-B2 | Reactive compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-12-06 | — | — | US | disclosed |
| US-20080138651-A1 | Polyanilines; strong fluorescence and large charge transporting properties | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-06-12 | — | — | US | disclosed |
| US-20080118773-A1 | Complex Composition, Polymer Complex Compound And Polymer Light-Emitting Device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-05-22 | — | — | US | disclosed |
| US-20080003422-A1 | Polymer Compound, Polymer Thin Film and Polymer Thin Film Device Using the Same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-01-03 | — | — | US | disclosed |
| US-20070103059-A1 | Composition and polymer light-emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070051922-A1 | Polymer light-emitting material and polymer light-emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20070040164-A1 | Polymer complex compound and polymer light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-02-22 | — | — | US | disclosed |
| EP-0643045-B1 | Quinoline derivatives as leukotriene antagonists | NOVARTIS AG (CH) | 2000-03-08 | — | — | EP | disclosed |
| US-5508408-A | LEUKOTRIENE ANTAGONISTS | CIBA-GEIGY CORPORATION (US) | 1996-04-16 | — | — | US | disclosed |
| EP-0643045-A1 | Quinoline derivatives as leukoriene antagonists | CIBA-GEIGY AG (CH) | 1995-03-15 | — | — | EP | disclosed |
| EP-0198264-A2 | Carbamoyl imidazoles | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1986-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080138651-A1 | Polyanilines; strong fluorescence and large charge transporting properties | BRS3, SLC43A1, MRPS23 | CYP1A2 3318/4885KDM4E 3786/4885LMNA 1934/4885 |
| US-20160372675-A1 | MACROMOLECULAR COMPOUND | EXOSC4, TRPC6, MRPS22 | CYP1A2 4239/4885KDM4E 2826/4885LMNA 3835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.